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Can any two things be identical? The question has puzzled
metaphysicists since Leibniz proposed his ‘Identity of
Indiscernibles’ law four centuries ago. Average measure-
ments performed on large populations of cells are routine in
biochemistry and rest on the assumption—often made
implicitly—that genetically identical cells behave identically.
Since this approach prevents detecting anydifference between
single cells, the validity of this assumption remains un-
challenged. In cell biology, on the other hand, direct
observation of individual cells naturally raises the issue of
how and why isogenic cells look and behave differently from
one another. What are the biochemical explanations for the
differences between individual cells?
As nucleic acid detection methods have become more
sensitive, our ability to observe cell-to-cell variability in gene
expression has improved dramatically. We can now ask: what
are the sources, controlling factors, and biological roles of
stochastic variability in gene expression? Until now virtually
all of this work has been focused on transcription, with other
key steps in the gene expression pathway—splicing, RNA
decay,translation,proteinturnover—leftyettobestudied.Ina
study just published in Molecular Systems Biology (Waks et al,
2011), Pamela Silver and colleagues use single molecule
ﬂuorescent in situ hybridization (smFISH) to ﬁll this gap and
provide the ﬁrst direct view of alternative splicing at the single
cell level. Early hints that alternative splicing might vary
within an isogenic cell population came from studies using
clever dual ﬂuorescent protein-based reporters (Orengo et al,
2006, Newman et al, 2006, Stoilov et al, 2008), but part of the
cell-to-cell variation in reporter protein expression could
have been contributed bysteps other than alternative splicing.
By using smFISH to count alternatively spliced mRNA
transcripts at the single molecule level, Waks and colleagues
directly sampled the cell-to-cell variation in spliced isoforms.
Why should we care about variation in alternative splicing,
or transcription—isn’t it just noise? Apparently evolution
cares, leading to situations in which critical developmental
decisions are left to a roll of the dice. A familiar example is the
lytic-lysogeny decision of the temperate bacteriophages like
lambda, beautifully deconstructed by Arkin et al (1998), who
modeled the contribution of stochastic events to this well-
described developmental decision.
Eukaryotic mRNAs from genetically identical cells show
surprisingly high levels of cell-to-cell variability in their
abundance. Importantly, these ﬂuctuations have impact on
developmental decisions in stem cells (Chang et al, 2008),
cancer cells (Spencer et al, 2009), and HIV-1-infected cells
(Weinberger et al, 2008). Along with differences in expression
levels, mRNAs generated byalternative splicing can also differ
in their coding sequence, which leads to differently function-
ing proteins or alternate regulatory control through non-sense
mediated mRNA decay (NMD). Since 490% of human genes
generate multiple distinct mRNAs, it simply won’t do to count
the total number of transcripts from each gene—we must take
into account each mRNA isoform separately. This complexity
is embraced by Waks et al and resolved for alternatively
spliced mRNAs from two human genes, CAPRIN1 and
MKNK2, in two human cell lines, Rpe1 and HeLa.
Inevitably, the application of smFISH to the question of
cell–cell variability in alternative splicing comes with
substantial technical constraints. A large (4800nt) target
sequence must be unique to at least one isoform because
multiple (ideally 450) speciﬁc, ﬂuorescently labeled oligonu-
cleotides mustbe hybridized (to ﬁxed cells)in order to detect a
ﬂuorescent dot representing the transcript. This restriction
leaves many isoforms that differ critically by the size of a
typical alternative exon for future investigations. Even so,
the CAPRIN1 and MKNK2 genes in this study produce
isoforms with distinct biological functions, and their varia-
bility has been captured for two distinct clonal cell lines,
Rpe1—a diploid cell line derived from retinal pigment
epithelial cells and HeLa—a cervical epithelial cancer cell line.
Intriguingly, isoform ratio variability is less in Rpe1 cells
than in HeLa cells, where it is considerable. For Rpe1, the
data are a close ﬁt to a binomial model of distribution
without invoking feedback. Thus, different cells have different
mRNA isoform variability. What causes this and how is it
regulated?
The authors address several possible sources of variability
beyondtheintrinsicstochasticityofalternativesplicingchoice,
including (1) ﬂuctuation in mRNA synthesis, (2) ﬂuctuation in
splicingfactors,(3)ﬂuctuationinrelativedecaytimesbetween
isoforms, and (4) variability due to cell-cycle stage. Examina-
tion of these possible sources using modeling and other
measurements leads them to argue that cell-to-cell variation in
isoform ratio is likely due in large part to cell-to-cell variation
in the level of splicing regulators. They support this idea by
RNAi knockdown of SFSR1 (a.k.a. ASF/SF2—a splicing factor
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increase in MKNK2 isoform ratio cell-to-cell variability.
This offers tantalizing evidence that tight regulation of the
splicing machinery, in part through autogenous regulation of
splicing factors (Ni et al, 2007; Lareau et al, 2007) might
be an important general mechanism by which cells temper
ﬂuctuations in mRNA isoform ratios.
The work by Waks and colleagues provides a platform for
future studies of the mechanisms underlying single cell
expression heterogeneity. The broader application of these
techniques holds great promises for the exploration of
stochastic ﬂuctuations in alternative splicing and their role
in complex developmental decisions or in clinical relevant
processes affecting, for example, disease progression and
efﬁcacy of therapeutic treatments. Leibniz’s law of identity is
determined by the discernability of two objects’ character-
istics. With the study by Waks et al, single cell isoform ratios
can now be discerned uncovering yet another way in which
genetically identical cells are not identical, and thus may
diverge in their biological trajectories.
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